Safety, Tolerability, and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine (coronavac) in Healthy Adults Aged 60 Years and Older: a Randomised, Double-Blind, Placebo-Controlled, Phase 1/2 Clinical Trial
Lancet Infectious diseases/The Lancet Infectious diseases（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined